Company Filing History:
Years Active: 2016-2018
Title: Inventor Spotlight: Anna Moosmann
Introduction
Anna Moosmann is a prominent inventor based in Winterbach, Germany. She has made significant contributions to the field of antiviral pharmaceuticals, evidenced by her three patents. Her innovative work continues to impact the way antiviral medications are developed and utilized.
Latest Patents
Among her latest patents, Anna has focused on solid antiviral dosage forms. These patents involve solid dosage forms that incorporate antiviral compounds and detail methods for using them to treat antiviral infections. This innovative approach facilitates more effective treatment options for patients suffering from various viral infections.
Career Highlights
Anna currently works at AbbVie Inc., a global biopharmaceutical company where she applies her expertise in drug development. Her role at AbbVie has allowed her to delve deeper into research and innovation within the pharmaceutical sector.
Collaborations
Throughout her career, Anna Moosmann has collaborated with notable coworkers, including Jonathan Mark Miller and John B. Morris. These partnerships have been instrumental in advancing her research and augmenting the collective knowledge within her field.
Conclusion
Anna Moosmann stands out as an influential inventor whose work on antiviral dosage forms has the potential to enhance treatment options worldwide. Her commitment to innovation and collaboration underscores her significant role in the field of pharmaceuticals, paving the way for future advancements in antiviral therapies.